NCT00319748 arm group 3afe5f3ac81568b326a8ef52864ac11a [clinicaltrials_resource:NCT00319748/arm-group/3afe5f3ac81568b326a8ef52864ac11a]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00319748 arm group 3afe5f3ac81568b326a8ef52864ac11a [clinicaltrials_resource:NCT00319748/arm-group/3afe5f3ac81568b326a8ef52864ac11a]
Bio2RDF identifier
NCT00319748/arm-group/3afe5f3ac81568b326a8ef52864ac11a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... fe5f3ac81568b326a8ef52864ac11a
description [clinicaltrials_vocabulary:description]
Patients treated with at least one dose - 852A subcutaneous injection.
identifier
clinicaltrials_resource:NCT00319748/arm-group/3afe5f3ac81568b326a8ef52864ac11a
title
NCT00319748 arm group 3afe5f3ac81568b326a8ef52864ac11a
@en
type
label
NCT00319748 arm group 3afe5f3a ...... e5f3ac81568b326a8ef52864ac11a]
@en